Literature DB >> 6389361

A plasmid-encoded outer membrane protein, TraT, enhances resistance of Escherichia coli to phagocytosis.

M E Agüero, L Aron, A G DeLuca, K N Timmis, F C Cabello.   

Abstract

The presence of the outer membrane protein TraT, encoded by plasmid R6-5, reduces the sensitivity of Escherichia coli cells to phagocytosis by macrophages. This effect is independent of the bacterial capsule and is more evident in the presence of adsorbed normal human serum. The property of inhibiting phagocytosis is specifically abolished by anti-TraT protein antiserum and anti-TraT immunoglobulin G but not by Fab fragments. These results indicate that the TraT protein is a passive inhibitor of phagocytosis. Inhibition of phagocytosis is produced because the TraT protein antagonizes opsonization by complement, such that C3 deposition is reduced and altered in distribution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389361      PMCID: PMC261607          DOI: 10.1128/iai.46.3.740-746.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Cloning, isolation, and characterization of replication regions of complex plasmid genomes.

Authors:  K Timmis; F Cabello; S N Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Effect of protein A on staphylococcal opsonization.

Authors:  P K Peterson; J Verhoef; L D Sabath; P G Quie
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

3.  Electron microscope heteroduplex studies of sequence relations among plasmids of Escherichia coli. II. Structure of drug resistance (R) factors and F factors.

Authors:  P A Sharp; S N Cohen; N Davidson
Journal:  J Mol Biol       Date:  1973-04-05       Impact factor: 5.469

4.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.

Authors:  C J Howard; A A Glynn
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

5.  Plasmid-controlled colonization factor associated with virulence in Esherichia coli enterotoxigenic for humans.

Authors:  D G Evans; R P Silver; D J Evans; D G Chase; S L Gorbach
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

6.  Replication control in a composite plasmid constructed by in vitro linkage of two distinct replicons.

Authors:  F Cabello; K Timmis; S N Cohen
Journal:  Nature       Date:  1976-01-29       Impact factor: 49.962

7.  Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA.

Authors:  S N Cohen; A C Chang; L Hsu
Journal:  Proc Natl Acad Sci U S A       Date:  1972-08       Impact factor: 11.205

8.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.

Authors:  F M Griffin; J A Griffin; J E Leider; S C Silverstein
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Segmental response of the macrophage plasma membrane to a phagocytic stimulus.

Authors:  F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1974-02-01       Impact factor: 14.307

View more
  26 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 2.  TraT lipoprotein, a plasmid-specified mediator of interactions between gram-negative bacteria and their environment.

Authors:  S Sukupolvi; C D O'Connor
Journal:  Microbiol Rev       Date:  1990-12

3.  Interaction of complement with serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.

Authors:  N L Schiller; K A Joiner
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

4.  Comparison of virulence factors and R plasmids of Salmonella spp. isolated from healthy and ill swine.

Authors:  K W Simmons; R E Wooley; J Brown
Journal:  Appl Environ Microbiol       Date:  1988-03       Impact factor: 4.792

5.  Survey of purported virulence factors of Escherichia coli isolated from blood, urine and stool.

Authors:  S M Opal; A Cross; P Gemski; L W Lyhte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

6.  Amino acid alterations in a hydrophobic region of the TraT protein of R6-5 increase the outer membrane permeability of enteric bacteria.

Authors:  S Sukupolvi; D O'Connor
Journal:  Mol Gen Genet       Date:  1987-11

7.  Immunoglobulin-binding activity among pathogenic and carrier isolates of Haemophilus somnus.

Authors:  P R Widders; L A Dorrance; M Yarnall; L B Corbeil
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

8.  Comparison of virulence gene profiles of Escherichia coli strains isolated from healthy and diarrheic swine.

Authors:  Toni A Chapman; Xi-Yang Wu; Idris Barchia; Karl A Bettelheim; Steven Driesen; Darren Trott; Mark Wilson; James J-C Chin
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

9.  A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

Authors:  R W Tindle; S Croft; K Herd; K Malcolm; A F Geczy; T Stewart; G J Fernando
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 10.  The virulence plasmid of Yersinia, an antihost genome.

Authors:  G R Cornelis; A Boland; A P Boyd; C Geuijen; M Iriarte; C Neyt; M P Sory; I Stainier
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.